# Early Prevention of Preeclampsia Study

> **NCT01547390** · NA · TERMINATED · sponsor: **Washington University School of Medicine** · enrollment: 104 (actual)

## Conditions studied

- Preeclampsia

## Interventions

- **DRUG:** Aspirin
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01547390
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-03
- **Primary completion:** 2015-07-20
- **Final completion:** 2015-07-20
- **Target enrollment:** 104 (ACTUAL)
- **Why stopped:** Terminated after Aspirin was recommended by the USPTF to Prevent Preeclampsia.
- **Last updated:** 2018-06-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01547390

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01547390, "Early Prevention of Preeclampsia Study". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01547390. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*